Feasibility of FMISO in Brain Tumors

NCT03649880 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Malignant Brain Neoplasm

Interventions

DRUG: ¹⁸F-Fluoromisonidazole
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
PROCEDURE: Oxygen Therapy

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]